Orange Book product · Brand (NDA)
HALCION
TRIAZOLAM
At a glance
Apr 26, 1985
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 26, 1985
41 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
TRIAZOLAM
Strength
0.125MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 017892
Product number
003
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2022TRIAZOLAMGeneric (ANDA)
ANDA 213003 · ZYDUS PHARMS
- 2022TRIAZOLAMGeneric (ANDA)
ANDA 216890 · BRECKENRIDGE
- 2020TRIAZOLAMGeneric (ANDA)
ANDA 214219 · INGENUS PHARMS LLC
- 1995TRIAZOLAMGeneric (ANDA)
ANDA 074445 · WATSON LABS
- 1994TRIAZOLAMGeneric (ANDA)
ANDA 074224 · HIKMA
- 1994TRIAZOLAMGeneric (ANDA)
ANDA 074031 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
